Cytoki Pharma Alternatives & Competitors
12 companies similar to Cytoki Pharma — Leveraging lipidated IL-22 to treat metabolic diseases and IBD
Companies similar to Cytoki Pharma
Simcha Therapeutics
Overcoming biological challenges in clinically translatable pathways.
New Haven, United States
Entact Bio
Creating new medicines by enhancing protein function
Watertown, United States
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
Laminar Pharma
Biopharmaceutical company performing discovery, rational design and initial clinical devel...
Spain
Rival Readout
Competing with Cytoki Pharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Exalys Therapeutics
Creating breakthrough anti-inflammatory therapeutics to address urgent medical needs, star...
Xenikos B.V.
Developing new, innovative immunotherapy medicines that reset the immune system
Nijmegen, The Netherlands
Memgen, Inc.
Memgen's Vision: Develop Life-Saving Cancer Immunotherapies
Houston, United States
Treeline
Making medicines at the highest level
Watertown, United States
Cerberus Therapeutics
Modulating immunity with the small—yet, mighty—nanobody
Cambridge, United States
Walking Fish Therapeutics, Inc.
Engineering B Cell‐Based Protein Factories to Treat Serious Diseases.
South San Francisco, Unit...
Quercis Pharma
For a Healthier World
Zug, Switzerland
Rubedo Life Sciences
Medicines to keep you biologically young by targeting the pathological cells that drive ch...
Sunnyvale, United States
About Cytoki Pharma
Cytoki Pharma, founded in 2019, is a pioneering clinical-stage biotechnology company based in Denmark. Specializing in the development of novel medicines, the company is leveraging lipidated IL-22 to target both metabolic diseases and inflammatory bowel disease (IBD). Their innovative approach positions them as a cutti...
Development of IL-22 analogues, Phase 2 clinical evaluation of CK-10045, Creation of therapies for metabolic and epithelial-related diseases
Patients with metabolic diseases, Individuals suffering from obesity, People with type 2 diabetes, Patients with inflammatory bowel disease, Healthcare professionals in metabolic and inflammatory diseases
Clinical Stage, Metabolic Diseases, Inflammatory Bowel Disease (IBD), Epithelial Injury, Immune System Modulation, Cytokine Therapy, IL-22 Biology, Protein Engineering, Long-acting Proteins, Novel Medicines, Unmet Medical Needs, Drug Development, Organ Injury Treatment
B2B, B2B2C
Licensing, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Cytoki Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Cytoki Pharma on 15 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
